Successful management of postoperative acute respiratory distress syndrome in a patient with lung cancer

被引：0

作者：

Iyoda A. ^{[1
]}

Moriya Y. ^{[1
]}

Hiroshima K. ^{[2
]}

Shibuya K. ^{[1
]}

Yoshino I. ^{[1
]}

机构：

[1] Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chuo-ku, Chiba 260-8670

[2] Diagnostic Pathology, Graduate School of Medicine, Chiba University, Chiba

来源：

General Thoracic and Cardiovascular Surgery | 2008年 / 56卷 / 7期

关键词：

ARDS; Lung cancer; Neutrophil elastase inhibitor; Operation;

D O I：

10.1007/s11748-008-0254-7

中图分类号：

学科分类号：

摘要：

Acute respiratory distress syndrome after pulmonary resection for lung cancer frequently has a lethal outcome. Treatment with a combination therapy of neutrophil elastase inhibitor and steroid administration was used to achieve good control, without impairing lung function, in a patient with postoperative acute respiratory distress syndrome. A 74-year-old man was diagnosed with lung cancer and referred to the outpatient department of Chiba University Hospital with double primary lung cancers located in the right upper lobe that were staged at T2N0M0 (stage IB). He underwent right upper lobectomy with hilar and mediastinal lymph node dissection. After 10 postoperative days, he had acute respiratory distress syndrome. He was given a corticosteroid and a neutrophil elastase inhibitor, which resulted in rapid improvement without lung dysfunction. © 2008 The Japanese Association for Thoracic Surgery.

引用

页码：354 / 356

页数：2

共 9 条

[1] Parker S.L., Tong T., Bolden S., Wingo P.A., Cancer statistics, 1997, CA Cancer J Clin, 47, pp. 5-27, (1997)
[2] Kutlu C.A., Williams E.A., Evans T.W., Pastorino U., Goldstraw P., Acute lung injury and acute respiratory distress syndrome after pulmonary resection, Ann Thorac Surg, 69, pp. 376-380, (2000)
[3] Ruffini E., Parola A., Papalia E., Filosso P.L., Mancuso M., Oliaro A., Et al., Frequency and mortality of acute lung injury and acute respiratory distress syndrome after pulmonary resection for bronchogenic carcinoma, Eur J Cardiothorac Surg, 20, pp. 30-37, (2001)
[4] Tamakuma S., Ogawa M., Aikawa N., Kubota T., Hirasawa H., Ishizaka A., Et al., Relationship between neutrophil elastase and acute lung injury in humans, Pulm Pharmacol Ther, 17, pp. 271-279, (2004)
[5] Lee H.S., Lee J.M., Kim M.S., Kim H.Y., Hwangbo B., Zo J.I., Lowdose steroid therapy at an early phase of postoperative acute respiratory distress syndrome, Ann Thorac Surg, 79, pp. 405-410, (2005)
[6] Herridge M.S., Cheung A.M., Tansey C.M., Matte-Martyn A., Diaz-Granados N., Al-Saidi F., Et al., Canadian Critical Care Trials Group: One-year outcomes in survivors of the acute respiratory distress syndrome, N Engl J Med, 348, pp. 683-693, (2003)
[7] Bernard G.R., Luce J.M., Sprung C.L., Rinaldo J.E., Tate R.M., Sibbald W.J., Et al., High-dose corticosteroids in patients with the adult respiratory distress syndrome, N Engl J Med, 317, pp. 1565-15670, (1987)
[8] Hoshi K., Kurosawa S., Kato M., Andoh K., Satoh D., Kaise A., Sivelestat, a neutrophil elastase inhibitor, reduces mortality rate of critically ill patients, Tohoku J Exp Med, 207, pp. 143-148, (2005)
[9] Ryugo M., Sawa Y., Takano H., Matsumiya G., Iwai S., Ono M., Effect of a polymorphonuclear elastase inhibitor (sivelestat sodium) on acute lung injury after cardiopulmonary bypass: Findings of a double-blind randomized study, Surg Today, 36, pp. 321-326, (2006)

← 1 →